State MT
Clinical Trials in Montana
Recruiting clinical trials with at least one study location in Montana. Data updated daily from ClinicalTrials.gov.
Top Conditions in Montana
Lung Non-Small Cell Carcinoma (2)Stage II Lung Cancer AJCC v8 (2)Stage IIIA Lung Cancer AJCC v8 (2)Stage IIIB Lung Cancer AJCC v8 (2)Inflammation (2)Anatomic Stage IV Breast Cancer AJCC v8 (2)Breast Cancer (2)Ovarian Cancer (2)Anatomic Stage I Breast Cancer AJCC v8 (1)Anatomic Stage II Breast Cancer AJCC v8 (1)Anatomic Stage IIIA Breast Cancer AJCC v8 (1)Anatomic Stage IIIB Breast Cancer AJCC v8 (1)
Frequently Asked Questions — Clinical Trials in Montana
How many clinical trials are currently recruiting in Montana?
ClinicalMetric currently tracks 33 actively recruiting clinical trials with at least one location in Montana. The total number of registered studies—including active but not currently enrolling trials—is 33. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Montana?
Montana hosts clinical trials across a broad range of medical conditions, including Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Montana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Montana?
To join a clinical trial in Montana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Montana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Montana
NCT05929768 Phase 3
Recruiting
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple N...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
2,400 pts
Location
United States, Mexico, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT06154447 Phase 1
Recruiting
Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fib...
Condition
Cystic Fibrosis
Enrollment
255 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
NCT06952660 Phase 4
Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic C...
Condition
Cervical Cancer
Enrollment
100 pts
Location
United States, Puerto Rico
Sponsor
Pfizer
NCT06589804 Phase 3
Recruiting
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatme...
Condition
Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment
158 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT06958211 Phase 3
Recruiting
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants W...
Condition
Hidradenitis Suppurativa
Enrollment
550 pts
Location
United States, Belgium, Bulgaria
Sponsor
Incyte Corporation
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT03851445 Phase 2, Phase 3
Recruiting
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung...
Condition
Previously Treated Non-Small Cell Lung Cancer
Enrollment
10,000 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT07054866 N/A
Recruiting
Rural Autistic Individuals - Supporting Expression
Condition
Autism Disorder
Enrollment
50 pts
Location
United States
Sponsor
Montana State University
NCT06546020 N/A
Recruiting
Gut Microbiota-dependent Health Impacts of Haskap Berries
Condition
Metabolic Disease
Enrollment
120 pts
Location
United States
Sponsor
Montana State University
NCT03242642 N/A
Recruiting
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System ...
Condition
Mitral Valve Regurgitation
Enrollment
1,056 pts
Location
United States, Canada, Denmark
Sponsor
Medtronic Cardiovascular
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT05647265 Phase 2
Recruiting
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomato...
Condition
Pleural Biphasic Mesothelioma
Enrollment
26 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT00196742 N/A
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
Condition
Fabry Disease
Enrollment
9,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
NCT07144280 Phase 3
Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Do...
Condition
Non-small Cell Carcinoma
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT06777368 N/A
Recruiting
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failu...
Condition
Aortic Stenosis
Enrollment
225 pts
Location
United States
Sponsor
Medtronic Cardiovascular
NCT07133308 Phase 3
Recruiting
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With ...
Condition
Alopecia Areata
Enrollment
355 pts
Location
United States, Canada
Sponsor
Sun Pharmaceutical Industries,
NCT06112613 N/A
Recruiting
Mobile Health for Adherence in Breast Cancer Patients
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
410 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT04267848 Phase 3
Recruiting
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemoth...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
1,210 pts
Location
United States, Guam
Sponsor
National Cancer Institute (NCI
NCT05946213 Phase 3
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in...
Condition
Prostate Adenocarcinoma
Enrollment
1,209 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT06235697 Phase 3
Recruiting
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate...
Condition
Prostate Cancer
Enrollment
710 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT07064473 Phase 3
Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empag...
Condition
Diabetes Mellitus, Type 2
Enrollment
11,800 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
Page 1 of 2 — 33 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology